It should be noted that tests based on the methylation status of SEPT9 may serve as a competitive option for CRC screening and early detection, as it has been demonstrated to have a higher compliance than protein FIT tests and colonoscopy. The gene discussed is SEPTIN9; the disease is colorectal carcinoma.